Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amdocs (DOX) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Amdocs (DOX) over the last 17 years, with Q3 2025 value amounting to $13.2 million.

  • Amdocs' Gains from Investment Securities fell 5969.57% to $13.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $122.4 million, marking a year-over-year decrease of 3471.6%. This contributed to the annual value of $901000.0 for FY2025, which is 2226.06% down from last year.
  • Latest data reveals that Amdocs reported Gains from Investment Securities of $13.2 million as of Q3 2025, which was down 5969.57% from $30.2 million recorded in Q2 2025.
  • In the past 5 years, Amdocs' Gains from Investment Securities ranged from a high of $65.0 million in Q2 2023 and a low of $13.2 million during Q3 2025
  • For the 5-year period, Amdocs' Gains from Investment Securities averaged around $35.4 million, with its median value being $35.1 million (2023).
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first soared by 42971.07% in 2021, then tumbled by 5969.57% in 2025.
  • Quarter analysis of 5 years shows Amdocs' Gains from Investment Securities stood at $16.3 million in 2021, then skyrocketed by 159.33% to $42.4 million in 2022, then rose by 20.98% to $51.3 million in 2023, then fell by 3.33% to $49.5 million in 2024, then plummeted by 73.37% to $13.2 million in 2025.
  • Its Gains from Investment Securities stands at $13.2 million for Q3 2025, versus $30.2 million for Q2 2025 and $29.5 million for Q1 2025.